2026 NPPES data Transplant Surgery Physician NPI 1962002576
Verify on CMS →

BERJESH SHARDA

Transplant Surgery Physician in INDIANA, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
542
Medicare Part D claims · 144 beneficiaries · Transplant Surgery Physician avg: 275
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
93.7848/100
▲ 11 pts above national avg 83.1 · [object Object]
Industry payments
$312.82
12 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

BERJESH SHARDA reported a CMS MIPS final score of 93.7848/100 — above the 83.1 national average — and filed 542 Medicare Part D claims in 2023.

93.7848/100
MIPS score · +11 vs avg
542
Part D claims, 2023
90%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

BERJESH SHARDA's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

94 Top 29% higher than 71% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

BERJESH SHARDA practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about BERJESH SHARDA?

High performer (top quartile)

NPI registry status

Active

Issued 11/01/2020

NPI 1962002576

Primary specialty

Transplant Surgery Physician

Niche

1,026 US NPIs in this specialty

Medicare Part D claims

542 97% vs specialty avg

2023 prescription claims

Specialty avg: 275

MIPS final score

93.7848/100 10.68480000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Pennsylvania

How Transplant Surgery Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Transplant Surgery Physician share within Pennsylvania

1. Transplant Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Transplant Surgery Physician share within Pennsylvania

Medicare quality performance — MIPS

BERJESH SHARDA's 2023 MIPS final score plotted against the Transplant Surgery Physician national average

High performer (top quartile)
MIPS Final Score
93.7848/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Transplant Surgery Physician) — 93.7848/100 vs national avg 83.1

0%100%National avg83%93.8%
MIPS final score (Transplant Surgery Physician) — 93.7848/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

BERJESH SHARDA appears in the CMS NPPES registry as a Transplant Surgery Physician provider at 1265 WAYNE AVE STE 104, INDIANA, PA, 15701, with a listed phone of (724) 464-2719. NPI 1962002576 was issued on 11/01/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SHARDA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 542 prescription claims written by this provider, covering 144 Medicare beneficiaries and totaling roughly $25K in drug spend, split 10% brand-name and 90% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.7848/100 for the 2023 performance year (Quality 85.0781), compared with the national average of 83.1.

Transplant Surgery Physician is a narrow specialty nationwide, with 1,026 enrolled providers across 48 states and an average of 275 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1265 WAYNE AVE STE 104
INDIANA, PA 15701

Provider Details

NPI 1962002576
Specialty Transplant Surgery Physician
Gender Male
NPI Issued 11/01/2020

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

93.7848
Final Score
Avg: 83.1
85.0781
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where BERJESH SHARDA bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

INDIANA HEALTHCARE PHYSICIAN SERVICES INC
INDIANA, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BERJESH SHARDA. Source: openpaymentsdata.cms.gov.

Total received

$313

Largest payer

Janssen Biotech, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to BERJESH SHARDA. To verify BERJESH SHARDA's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

BERJESH SHARDA — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 542 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

542
Total Claims
$25K
Total Drug Cost
144
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
646
Total Day Supply
14,998
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$14K
Generic Drug Cost
$12K
Antibiotic Claims
162

Patient Demographics

Average Patient Age
71.4 years
Avg HCC Risk Score
1.41
Gender Split
40% female / 60% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What BERJESH SHARDA prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Tamsulosin Hcl
114
Levofloxacin
91
Tolterodine Tartrate
50
Dutasteride
44
Tolterodine Tartrate Er
Tolterodine Tartrate
41
Oxybutynin Chloride
35
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
29
Alfuzosin Hcl Er
Alfuzosin Hcl
21
Myrbetriq
Mirabegron
19
Oxybutynin Chloride Er
Oxybutynin Chloride
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Transplant Surgery Physician Overview

How BERJESH SHARDA fits within the Transplant Surgery Physician landscape nationally.

1,026
Transplant Surgery Physician Providers in US
48
States with Transplant Surgery Physician
275
Avg Claims per Provider

BERJESH SHARDA's 542 claims are above the specialty average of 275.

Nearby Transplant Surgery Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as SHARDA.

Compare Transplant Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is BERJESH SHARDA's specialty?
BERJESH SHARDA specializes in Transplant Surgery Physician and practices in INDIANA, Pennsylvania.
How much does BERJESH SHARDA prescribe under Medicare Part D?
In 2023, BERJESH SHARDA wrote 542 Medicare Part D claims totaling $25K in drug costs for 144 beneficiaries.
What is BERJESH SHARDA's Medicare quality score?
BERJESH SHARDA has a CMS MIPS Final Score of 93.7848/100 (Quality: 85.0781). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is BERJESH SHARDA located?
BERJESH SHARDA is located at 1265 WAYNE AVE STE 104, INDIANA, PA, 15701. Phone: (724) 464-2719.
What is BERJESH SHARDA's NPI number?
BERJESH SHARDA's National Provider Identifier (NPI) is 1962002576, issued on 11/01/2020.
Does BERJESH SHARDA prescribe more brand-name or generic drugs?
BERJESH SHARDA's prescribing is 10% brand-name and 90% generic drugs by claim count, with $14K in brand drug costs.
How many Transplant Surgery Physician providers are there in the US?
There are 1,026 Transplant Surgery Physician providers across 48 states in the US. The average Transplant Surgery Physician provider writes 275 Medicare Part D claims per year.
What drugs does BERJESH SHARDA prescribe most often?
Based on 2023 Medicare Part D data, BERJESH SHARDA's most frequently prescribed drugs include Tamsulosin Hcl, Levofloxacin, Tolterodine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does BERJESH SHARDA accept Medicare?
BERJESH SHARDA appears in CMS Medicare data with 542 Part D claims and 144 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify BERJESH SHARDA's credentials?
BERJESH SHARDA's NPI is 1962002576. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology